DCB-BO1301 | m-entrepreneurship.com

Product Name :
DCB-BO1301

Search keywords :
DCB

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Undisclosed

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
A2 Healthcare Corp

Active Company_Name :
Chung Mei Biopharma Co Ltd

Active Indication_Name:
Melanoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse CD8a Antibody (53-6.7) site
SUMO-1 Rabbit mAb Protocol
ALIX Antibody: ALIX Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to ALIX. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts